These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6139114)

  • 41. Influence of indometacin and acetylsalicylic acid on the therapeutic effectiveness of talinolol in patients with essential hypertension.
    Sziegoleit W; Ehrhardt A; Haase P; Beitz J; Block HU; Fahr A
    Biomed Biochim Acta; 1984; 43(8-9):S463-6. PubMed ID: 6151396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Long-term hypotensive treatment by butofilolol].
    Toussain P; Gay G; Debry G
    Ann Cardiol Angeiol (Paris); 1983 Jun; 32(4):277-83. PubMed ID: 6412614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiclinic evaluation of timolol in the treatment of mild-to-moderate essential hypertension.
    Rofman BA; Kulaga SF; Gabriel MA; Thiyagarajan B; Nancarrow JF; Abrams WB
    Hypertension; 1980; 2(5):643-8. PubMed ID: 6998870
    [No Abstract]   [Full Text] [Related]  

  • 45. [International multicentre-study on indapamide in the treatment f essential arterial hypertension (author's transl)].
    Passeron J
    Schweiz Rundsch Med Prax; 1982 Feb; 71(7):293-6. PubMed ID: 7050963
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of salbutamol, indomethacin and atenolol on plasma renin activity in patients with essential arterial hypertension].
    Stornello M; Di Rao G; Iachello M; Bosco V; Pantano S; Pisani R; Scapellato L
    Minerva Nefrol; 1982; 29(3):159-64. PubMed ID: 6292792
    [No Abstract]   [Full Text] [Related]  

  • 47. A new approach to drug trials in general practice. Comparison of the antihypertensive efficacy of metoprolol and atenolol.
    Adams-Strump BJ; Hayes J; Barber JH
    Practitioner; 1980 May; 224(1343):541-4. PubMed ID: 6999485
    [No Abstract]   [Full Text] [Related]  

  • 48. Atenolol v placebo in mild hypertension: renal metabolic and stress antipressor effects.
    Waal-Manning HJ; Bolli P
    Br J Clin Pharmacol; 1980 Jun; 9(6):553-60. PubMed ID: 6992822
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of hypertension with a beta receptor blocker in a sanatorium].
    Metzger K; Schrey A; Nauheim B
    Med Welt; 1979 Jan; 30(4):150-2. PubMed ID: 368496
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of high blood pressure with Betadrenol 100. Results of a clinical study].
    Malig W; Grund R; Schrey A
    ZFA (Stuttgart); 1980 Oct; 56(30):2047-52. PubMed ID: 7008414
    [No Abstract]   [Full Text] [Related]  

  • 51. [Betadrenol 100 in the management of hypertension in practice. Report on a study using Bupranolol].
    Schrey A
    Med Welt; 1979 Mar; 30(12):451-7. PubMed ID: 106216
    [No Abstract]   [Full Text] [Related]  

  • 52. Penbutolol: a new beta blocker in the treatment of moderate essential hypertension.
    Cangiano JL; Ayala JM; Boksay IJ; Martinez-Maldonado M
    J Clin Pharmacol; 1979 Jul; 19(7):384-9. PubMed ID: 479383
    [No Abstract]   [Full Text] [Related]  

  • 53. Oxprenolol in hypertension.
    Marshall AJ; Barritt DW
    Br J Clin Pract; 1973 Sep; 27(9):337-40. PubMed ID: 4595073
    [No Abstract]   [Full Text] [Related]  

  • 54. A comparison of the antihypertensive effects of furosemide and chlorothiazide.
    Bariso CR; Hanenson IB; Gaffney TE
    Curr Ther Res Clin Exp; 1970 Jun; 12(6):333-40. PubMed ID: 4987341
    [No Abstract]   [Full Text] [Related]  

  • 55. [Management of hypertension using Bupranolol. Report on experience].
    Schrey A
    Med Welt; 1979 Jul; 30(28):1098-100. PubMed ID: 381835
    [No Abstract]   [Full Text] [Related]  

  • 56. Systemic hemodynamic effects of R-epinephrine gingival retraction cord in clinic patients.
    Phatak NM; Lang RL
    J Oral Ther Pharmacol; 1966 May; 2(6):393-8. PubMed ID: 5334252
    [No Abstract]   [Full Text] [Related]  

  • 57. [On the blood-pressure effect and the therapeutic applications of Peripherin].
    Thaler H
    Wien Klin Wochenschr; 1965 Dec; 77(51):1014-8. PubMed ID: 5331455
    [No Abstract]   [Full Text] [Related]  

  • 58. Cardiovascular and respiratory function values in hyperthermia: the effect of beta-receptor blockade with bunitrolol.
    Bühring M; Kemmerer K; Kappos A
    Klin Wochenschr; 1982 Jun; 60(12):617-23. PubMed ID: 6125625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Newer beta blockers and the treatment of hypertension.
    McAreavey D; Vermeulen R; Robertson JI
    Cardiovasc Drugs Ther; 1991 Jun; 5(3):577-87. PubMed ID: 1678961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antihypertensive effects of bunitrolol in essential hypertension.
    Yoshimura M; Shikuma R; Takashina R; Takeda K; Takahashi H; Ijichi H; Kajita Y; Yamazaki H
    Arzneimittelforschung; 1983; 33(8):1181-4. PubMed ID: 6139114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.